Radiology and Oncology (Nov 2022)

FDG PET-CT as an important diagnostic tool and prognostic marker in suspected recurrent cervical carcinoma after radiotherapy: comparison with MRI

  • Stojiljkovic Milica,
  • Sobic Saranovic Dragana,
  • Odalovic Strahinja,
  • Popovic Marina,
  • Petrovic Jelena,
  • Rankovic Nevena,
  • Veljkovic Milos,
  • Artiko Vera

DOI
https://doi.org/10.2478/raon-2022-0042
Journal volume & issue
Vol. 56, no. 4
pp. 453 – 460

Abstract

Read online

Recurrent disease in post-irradiation patients with cervical cancer is often difficult to delineate on magnetic resonance imaging (MRI), because posttreatment changes can have a similar appearance, and further evaluation is often required. The aims of the study were to evaluate positron emission tomography/computed tomography with 18F-fluorodeoxyglucose (FDG PET-CT) diagnostic role in suspected recurrent cervical cancer after radiotherapy, compare it to MRI, and assess their prognostic impact in these patients.

Keywords